Akari Therapeutics (AKTX) Profit After Tax Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 33.04% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.60% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -154.28% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.53% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -154.28% |
| Jun 30, 2025 | 30.64% |
| Mar 31, 2025 | 10.55% |
| Dec 31, 2024 | -141.30% |
| Sep 30, 2024 | -25.88% |
| Jun 30, 2024 | -20.25% |
| Mar 31, 2024 | 1.58% |
| Dec 31, 2023 | 15.30% |
| Sep 30, 2023 | -72.61% |
| Jun 30, 2023 | 18.69% |
| Mar 31, 2023 | 25.99% |
| Jun 30, 2022 | 1.52% |
| Mar 31, 2022 | -59.18% |
| Dec 31, 2021 | 74.43% |
| Sep 30, 2021 | 26.08% |
| Jun 30, 2021 | 18.48% |
| Mar 31, 2021 | -63.39% |
| Dec 31, 2020 | 17.48% |
| Sep 30, 2020 | 27.81% |
| Jun 30, 2020 | -185.41% |
| Mar 31, 2020 | -6,576.58% |
| Dec 31, 2019 | 1.87% |
| Sep 30, 2019 | -90.31% |
| Jun 30, 2019 | 2.67% |
| Mar 31, 2019 | 41.82% |
| Dec 31, 2018 | -36.49% |
| Sep 30, 2018 | 58.07% |
| Jun 30, 2018 | -81.54% |
| Mar 31, 2018 | 7.60% |
| Dec 31, 2017 | -121.59% |
| Sep 30, 2017 | -259.61% |
| Jun 30, 2017 | 47.64% |
| Mar 31, 2017 | -93.39% |